drug target discovery

Bioinformatics platforms are increasingly central to modern drug target discovery, transforming how biopharma organizations identify, validate, and prioritize therapeutic candidates. By integrating multi-omics datasets, advanced analytics, and machine learning models, these platforms are enabling more precise hypothesis generation while reducing early-stage attrition. In the United States, where regulatory expectations and commercialization timelines are tightly coupled, … Read more